RNA Therapy: Current Status and Future Potential

Chonnam Medical Journal
Young-Kook Kim


Recent studies identified diverse RNAs including noncoding RNAs and their various action mechanisms in the cells. These RNAs regulate a variety of cellular pathways and are therefore expected to be important targets for the treatment of human diseases. Along with their extensive functional studies, RNA-based therapeutic techniques have developed considerably in recent years. After years of research and various trial and error, antisense RNAs and small interfering RNAs-based drugs have been developed and are now being used in the clinic. In addition, active research is ongoing to develop drugs based on RNA aptamer and messenger RNA. Along with the development of these RNA-based drugs, diverse strategies have been developed to transport RNA drugs into the cells efficiently. RNA therapy has many advantages over existing small molecule or monoclonal antibody-based therapies, including its potential to target all genes in the cells. This review will introduce the history of RNA therapy, and explain the basic concepts of RNA therapy and RNA-based drugs on the market or clinical trials. In addition, the future potential of RNA therapy will be discussed.


Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P C Zamecnik, M L Stephenson
Mar 23, 1990·Science·J A WolffP L Felgner
Dec 1, 1968·Journal of Molecular Biology·R A Weinberg, S Penman
Jul 1, 1993·European Journal of Immunology·F MartinonP Meulien
Apr 30, 2002·Clinical Pharmacokinetics·Richard S GearyLisa R Grillone
Jul 5, 2002·Nature·Anton P McCaffreyMark A Kay
Aug 3, 2002·Science·György Hutvágner, Phillip D Zamore
Dec 31, 2004·The New England Journal of Medicine·Evangelos S GragoudasUNKNOWN VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group
Feb 26, 2009·Cell·Richard W Carthew, Erik J Sontheimer
Aug 18, 2012·Survey of Ophthalmology·Jin-Hong ChangDimitri T Azar
Dec 18, 2012·Expert Opinion on Biological Therapy·Amanda J Hooper, John R Burnett
May 10, 2013·Annual Review of Biophysics·Ross C Wilson, Jennifer A Doudna
Feb 11, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cornelia LorenzerJohannes Winkler
Dec 14, 2016·The New England Journal of Medicine·Kevin FitzgeraldAmy Simon
Dec 15, 2016·Bioconjugate Chemistry·Xiangang HuangBastien Castagner
Mar 11, 2017·Drug Design, Development and Therapy·Kenji Rowel Q LimToshifumi Yokota
Mar 31, 2017·Science Translational Medicine·Chris FinanJuan P Casas
Jun 29, 2017·Genome Medicine·James C KaczmarekDaniel G Anderson
Jan 13, 2018·Nature Reviews. Drug Discovery·Norbert PardiDrew Weissman
Apr 24, 2018·Nucleic Acid Therapeutics·Jayesh A KulkarniRoy van der Meel
Jul 5, 2018·The New England Journal of Medicine·David AdamsOle B Suhr
Jul 5, 2018·The New England Journal of Medicine·Merrill D BensonTeresa Coelho
Aug 22, 2018·Theranostics·Harleen KaurTarun Kumar Sharma
Oct 23, 2018·Science Advances·C ÄmmäläS Andersson
Feb 7, 2019·The New England Journal of Medicine·Eliane SardhKarl E Anderson
Apr 26, 2019·Advanced Drug Delivery Reviews·Nathan D DonahueStefan Wilhelm
Jun 19, 2019·Nature Reviews. Neurology·David AdamsTeresa Coelho

❮ Previous
Next ❯


Jan 23, 2021·Cells·Palas K ChandaJohn P Cooke
Apr 6, 2021·Molecular Therapy. Nucleic Acids·Juhyun Song, Young-Kook Kim
Dec 15, 2020·Trends in Biochemical Sciences·Thi Khanh LePalma Rocchi
Jul 3, 2021·Pharmaceutics·Noha AttiaJose Luis Pedraz
Aug 7, 2021·Life·Andreea CrinteaAlexandra Marioara Craciun
Aug 10, 2021·Molecular Aspects of Medicine·Alysia CoxEun Ji Chung
Sep 2, 2021·Current Atherosclerosis Reports·Neil C HenneyPeter E Penson
Sep 1, 2021·Journal of Industrial Microbiology & Biotechnology·Evelyn C Mollocana-LaraFernando A Gonzales-Zubiate
Oct 28, 2021·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Andrea L J Marschall

❮ Previous
Next ❯

Methods Mentioned

antisense oligonucleotides
antisense oligonucleotide
chemical modifications

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Frontiers in Bioengineering and Biotechnology
Tulsi Ram DamaseJohn P Cooke
Current HIV Research
José A Reyes-DariasAlfredo Berzal-Herranz
© 2021 Meta ULC. All rights reserved